Trials / Completed
CompletedNCT02082457
Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation
Multi-center, Randomized, Double Blinded, Placebo-controlled, Phase II Trial to Assess the Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 273 (actual)
- Sponsor
- SK Chemicals Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This trial is to investigate efficacy and safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation. The difference of responder rate between test group (10, 20 and 40mg) and placebo will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YKP10811 5mg | |
| DRUG | YKP10811 20mg | |
| DRUG | YKP10811 placebo |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-03-10
- Last updated
- 2015-06-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02082457. Inclusion in this directory is not an endorsement.